Cipla successfully opposes patent through post grant opposition

Cipla  successfully opposed the grant of a patent to Boehringer for Tiotropium Bromide Monohydrate branded as Spiriva.This is utilized in inhalers.The patent was successfully opposed on the basis that it did not enhance therapeutic efficacy.